The point of care diagnostics market has witnessed promising trends in the recent past, with microfluidics technology being at the cornerstone of this emerging field. Processes which are normally carried out in a lab can be miniaturized on a single chip to enhance analysis, diagnostic efficiency, and speed by reducing sample and reagent volumes. The developing microfluidics technology is revolutionising the way patients are diagnosed, monitored, and treated.

Microfluidics lab on chip technology is a promising approach for point of care diagnostics. Low reagent consumption, high sensitivity, and quick analysis time are the most prominent benefits offered by this platform. This technology has also been benefited from investments from government funding agencies to venture capitalists especially in Europe and North America, directed specifically towards the development of practical devices. Increase in focus on health outcomes, decentralization of healthcare, and rise in home care testing & monitoring is likely to boost adoption of this technology in near future. The specialists in this industry concluded that microfluidics technology will not only make diagnostics cheaper or affordable, but will simultaneously reduce the pressure on hospitals and the overall healthcare system.

Thus, rising adoption of microfluidics technology would propel the growth of point of care diagnostics market, which is expected to grow at CAGR of 8% to reach $30.9 billion by 2024, according to the Meticulous Research®.

Browse in depth Report:

Tags: Healthcare Point of Care / Rapid Testing


Related Reports